Selecting a site will automatically redirect you to the site's homepage.
Immunotherapy has not worked well against fibrolamellar carcinoma, but a new study finds an existing FDA-approved drug may allow the treatment to fight the cancer as intended.
A nationwide campaign that resulted in hundreds of scientists publishing letters in their hometown newspapers about the value of federal research funding has received the Meeting the Moment for Public Health Award from the non-profit Research!America.
More than $520 million in contributions from David A. Duffield ’62, MBA ’64 – including a new pledge of $371.5 million and a 2025 commitment of $100 million, combined with previous gifts – will establish the Cornell David A. Duffield College of Engineering.
